Common genetic variant linked to AFib risk in Latinos

April 9, 2018 by Jacqueline Carey, University of Illinois at Chicago
Dr. Dawood Darbar. Credit: UIC/Jenny Fontaine

"There is a paradox at play when it comes to atrial fibrillation in the Latino population," said Dr. Dawood Darbar.

"While Latino individuals are less likely to develop atrial fibrillation than whites, despite having a higher burden of risk factors, they are more likely to suffer complications if the condition does develop," said Darbar, professor medicine and pharmacology in the University of Illinois at Chicago College of Medicine.

Understanding this paradox has been a challenge because most research on the genetic basis of , or AFib, has been performed in whites of European descent.

With the development of a large, diverse registry of patients with AFib, the most prevalent heart rhythm disorder worldwide, Darbar and his colleagues at UIC have confirmed for the first time the association of a chromosomal genetic with increased risk of AFib in Latinos.

The findings are reported in PLOS ONE.

To identify common genetic variants, the researchers studied 713 patients who sought care at the University of Illinois Hospital in Chicago. The study group consisted of 103 Latino individuals who were prospectively enrolled in the UIC AFib Registry. Blood samples were analyzed for common genetic variants at a number of chromosomal locations and compared with genetic analysis results of 610 individuals without AFib.

"Our goal was to determine if the top nine gene variants known to be associated with AFib in white patients also increase susceptibility in Latinos," said Darbar, who is chief of cardiology.

"We found that one variant was also prevalent in Latinos with AFib, particularly those from Mexico," Darbar said, "and that its predictive effect was stronger in Latinos than in whites."

Latino were found to be at a 2.3-fold increased risk for developing AFib if they carried this , which is labeled rs10033464 SNP at chromosome 4q25.

Darbar says this finding not only sheds light on the underlying mechanisms of AFib, but it also, and more importantly, helps advance prevention and treatment strategies for AFib in Latinos.

"The presence of an AFib-associated genetic variant helps doctors personalize treatment for the individual patient," Darbar said. This is key, he says, to preventing complications, the most serious and common of which is stroke, which in some cases can lead to lifelong disability or death.

"It also alerts us to a possible familial link that can help identify when family members may also be at risk," Darbar said.

Explore further: Study backs up connection between atrial fibrillation and dementia

More information: Brandon Chalazan et al, Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort, PLOS ONE (2018). DOI: 10.1371/journal.pone.0194480

Related Stories

Study backs up connection between atrial fibrillation and dementia

March 7, 2018
One of the longest and most comprehensive studies to date has found more evidence that people diagnosed with a type of rapid or irregular heartbeat called atrial fibrillation may be at greater risk for cognitive decline and ...

Avoiding alcohol helps the heart beat better

October 19, 2017
(HealthDay)—The longer you refrain from drinking, the lower your risk of a common heart rhythm disorder.

Increasing percentage of patients aware of link between atrial fibrillation and stroke

September 6, 2012
(Medical Xpress)—Findings from a recent American Heart Association/American Stroke Association survey noted the increased awareness in patients suffering from atrial fibrillation and the correlation between this condition ...

Better models needed to predict risk of atrial fibrillation from medical records

October 12, 2016
An ounce of prevention is worth a pound of cure. That's why Dr. Dawood Darbar, chief of cardiology at the University of Illinois Hospital & Health Sciences System, worked with a team of physicians and researchers to answer ...

Guidelines suggest blood thinners for more women, seniors with AFib

March 2, 2015
Nearly all women and people over 65 in the U.S. with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute.

Atrial fibrillation hospitalizations rise as mortality rates decline

February 3, 2017
Patients with atrial fibrillation—the second most common cardiac condition—are hospitalized more frequently than in the past, but their survival rates are improving, says a new Yale-led study.

Recommended for you

Analytical tool predicts genes that can cause disease by producing altered proteins

July 19, 2018
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international ...

Childhood stress leaves lasting mark on genes

July 18, 2018
Kids who experience severe stress are more likely to develop a host of physical and mental health problems by the time they reach adulthood, including anxiety, depression and mood disorders. But how does early life stress ...

Study shows DNA methylation related to liver disease among obese patients

July 18, 2018
DNA methylation is a molecular process that helps enable our bodies to repair themselves, fight infection, get rid of environmental toxins, and even to think. But sometimes this process goes awry.

Protein found to be key component in irregularly excited brain cells

July 17, 2018
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumor ...

World's largest study on allergic rhinitis reveals new risk genes

July 17, 2018
An international team of scientists led by Helmholtz Zentrum München and University of Copenhagen has presented the largest study so far on allergic rhinitis in the journal Nature Genetics. The data of nearly 900,000 participants ...

New platform poised to be next generation of genetic medicines

July 16, 2018
A City of Hope scientist has discovered a gene-editing technology that could efficiently and accurately correct the genetic defects that underlie certain diseases, positioning the new tool as the basis for the next generation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.